Cargando…

Effect of Denosumab on Bone Mineral Density of Hematopoietic Stem Cell Transplantation Recipients

PURPOSE: Denosumab is a monoclonal antibody that prevents the development of osteoclasts. The effect of denosumab in solid organ transplant recipients has been elucidated, but its effect in haematopoietic stem cell transplantation recipients has not been studied yet. The aim of this study was to det...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Chaiho, Kim, Hee-Je, Lee, Seok, Kang, Moo Il, Ha, Jeonghoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218957/ https://www.ncbi.nlm.nih.gov/pubmed/32454821 http://dx.doi.org/10.1155/2020/3410921

Ejemplares similares

The Effect of Denosumab on Bone Mass in Super Elderly Patients
por: Jeong, Chaiho, et al.
Publicado: (2020)

Changes in Serum Dickkopf-1, RANK Ligand, Osteoprotegerin, and Bone Mineral Density after Allogeneic Hematopoietic Stem Cell Transplantation Treatment
por: Jang, Eunhee, et al.
Publicado: (2021)

Effect of Denosumab on Bone Density in Postmenopausal Osteoporosis: A Comparison with and without Calcium Supplementation in Patients on Standard Diets in Korea
por: Jeong, Chaiho, et al.
Publicado: (2023)

The efficacy of denosumab in Korean male patients with osteoporosis
por: Jeong, Chaiho, et al.
Publicado: (2022)

OR29-03 The Effects of Hormone Therapy on Premature Ovarian Failure Following Allogenic Hematopoietic Stem Cell Transplantation: A Single-Center Experience
por: Ha, Jeonghoon, et al.
Publicado: (2020)

Association of Hyperparathyroidism and Papillary Thyroid Cancer: A Multicenter Retrospective Study (Endocrinol Metab 2020;35:925–32, Chaiho Jeong et al.)
por: Jeong, Chaiho, et al.
Publicado: (2021)

Persistence with Denosumab in Male Osteoporosis Patients: A Real-World, Non-Interventional Multicenter Study
por: Jeong, Chaiho, et al.
Publicado: (2023)

Effect of Romosozumab on Trabecular Bone Score Compared to Anti-Resorptive Agents in Postmenopausal Women with Osteoporosis
por: Jeong, Chaiho, et al.
Publicado: (2021)

Effect of Romosozumab on Trabecular Bone Score Compared to Anti-Resorptive Agents in Postmenopausal Women with Osteoporosis
por: Jeong, Chaiho, et al.
Publicado: (2022)

Bone Mineral Density After Transitioning From Denosumab to Alendronate
por: Kendler, David, et al.
Publicado: (2019)

Pre-sarcopenia and bone mineral density in adults submitted to hematopoietic stem cell transplantation
por: Pereira, Cristiane Pavan, et al.
Publicado: (2017)

Bone mineral deficits in recipients of hematopoietic cell transplantation: the impact of young age at transplant
por: Petryk, Anna, et al.
Publicado: (2013)

Changes in bone mineral density and bone turnover markers in patients undergoing hematopoietic stem cell transplant
por: Pandit, Aditi, et al.
Publicado: (2015)

Effects of Denosumab on Bone Metabolic Markers and Bone Mineral Density in Patients Treated with Glucocorticoids
por: Sawamura, Masato, et al.
Publicado: (2017)

Mandibular radiomorphometric assessment of bone mineral density in survivors of pediatric hematopoietic stem-cell transplantation
por: Frascino, Alexandre Viana, et al.
Publicado: (2019)

Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
por: Chen, Yi, et al.
Publicado: (2021)

Osteoporosis Therapy With Denosumab in Organ Transplant Recipients
por: Brunova, Jana, et al.
Publicado: (2018)

Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis
por: Sánchez, A., et al.
Publicado: (2016)

Pretreatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy
por: Kamimura, Mikio, et al.
Publicado: (2018)

The Effects of Noncompliance to Prolia (Denosumab) on the Changes in Bone Mineral Density: A Retrospective Review
por: Wong-Pack, Matthew, et al.
Publicado: (2016)

Influence of denosumab on bone mineral density in a severe case of pregnancy-associated osteoporosis
por: Stumpf, U., et al.
Publicado: (2021)

Inverse association of serum osteocalcin and bone mineral density in renal transplant recipients
por: Lin, Wei-Chen, et al.
Publicado: (2022)

Fine-Needle Aspiration of Subcentimeter Thyroid Nodules in the Real-World Management
por: Jeong, Chaiho, et al.
Publicado: (2020)

Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
por: Kamimura, M., et al.
Publicado: (2016)

Bone and Joint Infections among Hematopoietic Stem Cell Transplant Recipients
por: Abad, Cybele Lara, et al.
Publicado: (2019)

Comparison of the Effects of Various Antidiabetic Medication on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus
por: Ha, Jeonghoon, et al.
Publicado: (2021)

Comparative effects of denosumab or bisphosphonate treatment on bone mineral density and calcium metabolism in postmenopausal women
por: Augoulea, A., et al.
Publicado: (2017)

Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study
por: Takami, Hiroya, et al.
Publicado: (2017)

Denosumab versus zoledronate for the treatment of low bone mineral density in male HIV-infected patients
por: Makras, Polyzois, et al.
Publicado: (2021)

Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis
por: Hu, Mingwei, et al.
Publicado: (2023)

Roles of Follicle-Stimulating Hormone on Bone Metabolism in Late Postmenopausal Women
por: Jeong, Chaiho, et al.
Publicado: (2022)

Impact of Hepatitis C Virus Infection on Bone Mineral Density in Renal Transplant Recipients
por: Huang, Wen-Hung, et al.
Publicado: (2013)

The Impact of Cholecaciferol Supplementation on Bone Mineral Density in Long-Term Kidney Transplant Recipients
por: Battaglia, Yuri, et al.
Publicado: (2023)

OR13-06 Romosozumab After Denosumab Improves Lumbar Spine Bone Mineral Density And Microarchitecture Greater Than Denosumab Continuation In Postmenopausal Women
por: Hong, Namki, et al.
Publicado: (2023)

Denosumab improves bone mineral density and microarchitecture and reduces bone pain in women with osteoporosis with and without glucocorticoid treatment
por: Petranova, Tzvetanka, et al.
Publicado: (2014)

Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
por: Kaneko, Tetsuya, et al.
Publicado: (2019)

Tuberculosis in Hematopoietic Stem Cell Transplant Recipients
por: Ramos, Jéssica Fernandes, et al.
Publicado: (2013)

Infection in the Hematopoietic Stem Cell Transplant Recipient
por: Marty, Francisco M., et al.
Publicado: (2008)

Infections in Recipients of Hematopoietic Stem Cell Transplants
por: Young, Jo-Anne H., et al.
Publicado: (2015)

Toxoplasma Encephalitis in an Allogeneic Hematopoietic Stem Cell Transplant Recipient in Korea
por: Park, Soo-Kyung, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hh2q4coq4g1rn7dp761p9e68er